Hering NA - Search Results

1

Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease.

Troeger H, Hering NA, Bojarski C, Fromm A, Barmeyer C, Uharek L, Siegmund B, Fromm M, Rieger K, Schulzke JD. Troeger H, et al. Among authors: hering na. Bone Marrow Transplant. 2018 Aug;53(8):1083-1086. doi: 10.1038/s41409-018-0144-2. Epub 2018 Mar 9. Bone Marrow Transplant. 2018. PMID: 29523887 No abstract available.

2

Therapeutic options to modulate barrier defects in inflammatory bowel disease.

Hering NA, Schulzke JD. Hering NA, et al. Dig Dis. 2009;27(4):450-4. doi: 10.1159/000233283. Epub 2009 Nov 4. Dig Dis. 2009. PMID: 19897959 Review.

3

Yersinia enterocolitica induces epithelial barrier dysfunction through regional tight junction changes in colonic HT-29/B6 cell monolayers.

Hering NA, Richter JF, Krug SM, Günzel D, Fromm A, Bohn E, Rosenthal R, Bücker R, Fromm M, Troeger H, Schulzke JD. Hering NA, et al. Lab Invest. 2011 Feb;91(2):310-24. doi: 10.1038/labinvest.2010.180. Epub 2010 Oct 18. Lab Invest. 2011. PMID: 20956974 Free article.

4

Transforming growth factor-β, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT-29/B6 cells.

Hering NA, Andres S, Fromm A, van Tol EA, Amasheh M, Mankertz J, Fromm M, Schulzke JD. Hering NA, et al. J Nutr. 2011 May;141(5):783-9. doi: 10.3945/jn.110.137588. Epub 2011 Mar 23. J Nutr. 2011. PMID: 21430244 Free article.

5

Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells.

Nielsen HL, Nielsen H, Ejlertsen T, Engberg J, Günzel D, Zeitz M, Hering NA, Fromm M, Schulzke JD, Bücker R. Nielsen HL, et al. Among authors: hering na. PLoS One. 2011;6(8):e23858. doi: 10.1371/journal.pone.0023858. Epub 2011 Aug 24. PLoS One. 2011. PMID: 21887334 Free PMC article.

6

Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics.

Hering NA, Fromm M, Schulzke JD. Hering NA, et al. J Physiol. 2012 Mar 1;590(5):1035-44. doi: 10.1113/jphysiol.2011.224568. Epub 2012 Jan 4. J Physiol. 2012. PMID: 22219336 Free PMC article. Review.

7

TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signaling in HT-29/B6 cells.

Hering NA, Richter JF, Fromm A, Wieser A, Hartmann S, Günzel D, Bücker R, Fromm M, Schulzke JD, Troeger H. Hering NA, et al. Mucosal Immunol. 2014 Mar;7(2):369-78. doi: 10.1038/mi.2013.55. Epub 2013 Jul 31. Mucosal Immunol. 2014. PMID: 23900194 Free article.

8

A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation.

Whelan RA, Rausch S, Ebner F, Günzel D, Richter JF, Hering NA, Schulzke JD, Kühl AA, Keles A, Janczyk P, Nöckler K, Wieler LH, Hartmann S. Whelan RA, et al. Among authors: hering na. Mol Ther. 2014 Oct;22(10):1730-40. doi: 10.1038/mt.2014.125. Epub 2014 Jul 2. Mol Ther. 2014. PMID: 24985163 Free PMC article.

9

Yersinia enterocolitica Affects Intestinal Barrier Function in the Colon.

Hering NA, Fromm A, Kikhney J, Lee IF, Moter A, Schulzke JD, Bücker R. Hering NA, et al. J Infect Dis. 2016 Apr 1;213(7):1157-62. doi: 10.1093/infdis/jiv571. Epub 2015 Nov 29. J Infect Dis. 2016. PMID: 26621910

10

Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells.

Rosenthal R, Luettig J, Hering NA, Krug SM, Albrecht U, Fromm M, Schulzke JD. Rosenthal R, et al. Among authors: hering na. Int J Colorectal Dis. 2017 May;32(5):623-634. doi: 10.1007/s00384-016-2736-x. Epub 2016 Dec 15. Int J Colorectal Dis. 2017. PMID: 27981377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters